Ubenimexum Uses, Dosage, Side Effects and more
Ubenimexum (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
| Trade Name | Ubenimexum |
| Generic | Ubenimex |
| Ubenimex Other Names | Ubenimex, Ubenimexum |
| Type | |
| Formula | C16H24N2O4 |
| Weight | Average: 308.3728 Monoisotopic: 308.173607266 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
An adjuvant therapy used for acute and chronic myelonous leukemia, lung cancer and nasopharyngeal cancer. It is also used to treat hypercholesterolaemia.
